 BioSig Technologies Inc has announced the appointment of Access Strategy Partners, Inc ASPI to advise the company on the next phase of its commercial roll-out. BioSig said the healthcare management firm is expected to enhance the companys market access strategy as BioSig expands the installation base of its signal processing technology for arrhythmia care. 